| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Peter-D Jensen | |
| P2860 | cites work | A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis | Q24310146 |
| Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress | Q24630216 | ||
| Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major | Q28279216 | ||
| The ferritins: molecular properties, iron storage function and cellular regulation | Q28609366 | ||
| Noninvasive measurement of iron: report of an NIDDK workshop | Q30741754 | ||
| Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange | Q31519753 | ||
| Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major | Q34331274 | ||
| Practical management of iron overload. | Q34434629 | ||
| SQUID biosusceptometry in the measurement of hepatic iron | Q35136586 | ||
| Ferritinaemia in Leukaemia and Hodgkin's Disease | Q36039852 | ||
| Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function | Q40774637 | ||
| Regulating the fate of mRNA: the control of cellular iron metabolism | Q40851091 | ||
| Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid | Q41310266 | ||
| The laboratory assessment of iron status--an update | Q41404270 | ||
| Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload | Q43628787 | ||
| MR relaxation times and iron content of thalassemic spleens: an in vitro study | Q43788593 | ||
| Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia | Q44145165 | ||
| Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias | Q44189651 | ||
| Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. | Q44308351 | ||
| Potential myocardial iron content evaluation by magnetic resonance imaging in thalassemia major patients treated with Deferoxamine or Deferiprone during a randomized multicenter prospective clinical study | Q44461257 | ||
| Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry | Q44465468 | ||
| Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis | Q47226630 | ||
| Myocardial iron deposition in beta-thalassemia studied by magnetic resonance imaging. | Q48002230 | ||
| Magnetic resonance imaging of the pituitary gland in patients with secondary hypogonadism due to transfusional hemochromatosis | Q48131139 | ||
| MR findings in pituitary haemosiderosis | Q48479231 | ||
| A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. | Q51666943 | ||
| Hepatic iron concentration and total body iron stores in thalassemia major. | Q52075941 | ||
| Iron in the heart | Q57636430 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 697-711 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Evaluation of iron overload | |
| P478 | volume | 124 |
| Q41839072 | A Room Temperature Ultrasensitive Magnetoelectric Susceptometer for Quantitative Tissue Iron Detection |
| Q47898588 | Advances in management of thalassemia |
| Q55399782 | An Ultrasensitive Magnetoelectric Sensor System For the Quantitative Detection of Liver Iron. |
| Q79443010 | Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores |
| Q48180147 | Clinical relevance of deferasirox trough levels in β-thalassemia patients |
| Q39662652 | Comparison between different software programs and post-processing techniques for the MRI quantification of liver iron concentration in thalassemia patients |
| Q38874222 | Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients. |
| Q43180472 | Deferoxamine versus combined therapy for chelating liver, spleen and bone marrow iron in beta-thalassemic patients: a quantitative magnetic resonance imaging study |
| Q38871298 | Electrocardiographic Presentation, Cardiac Arrhythmias, and Their Management in β-Thalassemia Major Patients. |
| Q50525194 | Evaluation of hepatic iron overload in Chinese children with β-thalassemia major. |
| Q31110125 | Evidence for a novel mechanism independent of myocardial iron in β-thalassemia cardiac pathogenesis |
| Q27022721 | Guidelines on haemovigilance of post-transfusional iron overload |
| Q36128148 | Hepatic veno-occlusive disease may develop in secondary iron overloaded mice after allogeneic hematopoietic stem cell transplantation with total body irradiation |
| Q41687355 | Influence of single-nucleotide polymorphisms on deferasirox C trough levels and effectiveness |
| Q30571110 | Iranian hereditary hemochromatosis patients: baseline characteristics, laboratory data and gene mutations |
| Q42446307 | Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine |
| Q36838132 | Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea |
| Q34165921 | Iron overload cardiomyopathy: better understanding of an increasing disorder |
| Q37670255 | Iron overload in Beta thalassaemia major and intermedia patients |
| Q37141962 | MR characterization of hepatic storage iron in transfusional iron overload. |
| Q53488461 | MR imaging of spleen in beta-thalassemia major. |
| Q53164559 | MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA. |
| Q56776157 | MRI assessment of changes in liver iron deposition post-venesection |
| Q34146691 | Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron. |
| Q36807710 | Measurement and correction of stimulated echo contamination in T2-based iron quantification |
| Q34160289 | Myocardial T2 quantitation in patients with iron overload at 3 Tesla. |
| Q35551172 | Noninvasive liver-iron measurements with a room-temperature susceptometer |
| Q31004810 | Perihematomal Cerebral Tissue Iron Quantification on MRI Following Intracerebral Hemorrhage in Two Human Subjects: Proof of Principle |
| Q46700826 | Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study |
| Q52642520 | Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration. |
| Q37054335 | Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes |
| Q34992619 | Reduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia. |
| Q48263712 | Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes |
| Q39865051 | Role of pharmacogenetics on deferasirox AUC and efficacy. |
| Q34143951 | Separate MRI quantification of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron |
| Q43199529 | T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman. |
| Q33801826 | Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. |
| Q91081280 | The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients |
| Q80703687 | [Diagnosis and quantification of iron overload in the liver using MRI] |
| Q46810400 | comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major |
Search more.